SPIA
ARNA

Steward Partners Investment Advisory’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Steward Partners Investment Advisory’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-50
Closed -$5K – 3447
2021
Q4 		$5K Hold
50
– – ﹤0.01% 2859
2021
Q3 		$3K Buy
+50
New +$2.95K ﹤0.01% 2963
2018
Q4 		– Sell
-50
Closed -$2K – 2391
2018
Q3 		$2K Hold
50
– – ﹤0.01% 2439
2018
Q2 		$2K Hold
50
– – ﹤0.01% 2286
2018
Q1 		$1K Hold
50
– – ﹤0.01% 2188
2017
Q4 		$1K Hold
50
– – ﹤0.01% 1830
2017
Q3 		$1K Hold
50
– – ﹤0.01% 1633
2017
Q2 		$0 Buy
+50
New +$686 ﹤0.01% 1726

Steward Partners Investment Advisory's ARNA Position: Q1 2022 in Review

Steward Partners Investment Advisory sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 50 shares — an estimated $5K sold.

Steward Partners Investment Advisory first reported a position in ARNA in Q2 2017 and held it in 8 quarters. The position peaked at $5K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Steward Partners Investment Advisory reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 50 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $5K.
  • Steward Partners Investment Advisory first reported a position in Arena Pharmaceuticals Inc in Q2 2017 and held it in 8 quarters.
  • Steward Partners Investment Advisory's Arena Pharmaceuticals Inc position peaked at $5K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2022, filed 2 May 2022.